Parascript, LLC, the image analysis and pattern recognition technology provider, today announced the release of AccuDetect 4.0, the next generation of its computer-aided detection (CAD) software with significant performance improvements and a greater potential for lowering false-positive rates when detecting suspicious lesions on mammograms, compared to the previous version of the product. Parascript AccuDetect 4.0 is unique in that it achieves high sensitivity and low false positive rates through the integration of several complimentary algorithms and a sophisticated voting scheme within a single CAD system.
Available for OEM customers interested in reducing false-positive rates of existing CAD systems, AccuDetect is intended to assist radiologists in the early detection of breast cancer during mammography screening exams.
AccuDetect is tuned to work with the leading full field digital and computed radiography vendors. The software recently received CE Mark approval and is deployed in the European Union.
"At Parascript, we are continually working towards improving the performance levels of our computer-aided detection algorithms to reach results comparable to the trained radiologist's eye," said Yuri Prizemin, director of product marketing for Parascript. "We are very excited to have made such significant strides as we have this year with AccuDetect."
CAD systems are typically relied upon to identify and highlight hard-to-find features and anomalies on medical images that may be indicative of cancer and bring them to the attention of radiologists. AccuDetect automatically identifies and clearly marks suspicious areas without obscuring the region of interest, enabling a more accurate interpretation of mammograms and increased detection of calcifications and masses.
Sapio Sciences Collaborates with Waters Corporation to Improve Efficiency of Laboratory Operations